2-[4-(1-adamantylcarbamoyl)phenyl]-N-(4-methoxyphenyl)-3H-benzimidazole-5-carboxamide;2-[4-(2-adamantylcarbamoyl)phenyl]-N-(4-methoxyphenyl)-3H-benzimidazole-5-carboxamide;2-[4-(cycloheptylcarbamoyl)phenyl]-N-pyridin-3-yl-3H-benzimidazole-5-carboxamide;2-[4-(cyclohexylcarbamoyl)phenyl]-N-pyridin-3-yl-3H-benzimidazole-5-carboxamide

C117H116N18O10 — CID 158541300

IUPAC2-[4-(1-adamantylcarbamoyl)phenyl]-N-(4-methoxyphenyl)-3H-benzimidazole-5-carboxamide;2-[4-(2-adamantylcarbamoyl)phenyl]-N-(4-methoxyphenyl)-3H-benzimidazole-5-carboxamide;2-[4-(cycloheptylcarbamoyl)phenyl]-N-pyridin-3-yl-3H-benzimidazole-5-carboxamide;2-[4-(cyclohexylcarbamoyl)phenyl]-N-pyridin-3-yl-3H-benzimidazole-5-carboxamide
SMILESCOc1ccc(NC(=O)c2ccc3nc(-c4ccc(C(=O)NC56CC7CC(CC(C7)C5)C6)cc4)[nH]c3c2)cc1.COc1ccc(NC(=O)c2ccc3nc(-c4ccc(C(=O)NC5C6CC7CC(C6)CC5C7)cc4)[nH]c3c2)cc1.O=C(Nc1cccnc1)c1ccc2nc(-c3ccc(C(=O)NC4CCCCC4)cc3)[nH]c2c1.O=C(Nc1cccnc1)c1ccc2nc(-c3ccc(C(=O)NC4CCCCCC4)cc3)[nH]c2c1
InChIInChI=1S/2C32H32N4O3.C27H27N5O2.C26H25N5O2/c1-39-26-9-7-25(8-10-26)33-30(37)24-6-11-27-28(15-24)35-29(34-27)22-2-4-23(5-3-22)31(38)36-32-16-19-12-20(17-32)14-21(13-19)18-32;1-39-26-9-7-25(8-10-26)33-32(38)22-6-11-27-28(17-22)35-30(34-27)20-2-4-21(5-3-20)31(37)36-29-23-13-18-12-19(15-23)16-24(29)14-18;33-26(29-21-6-3-1-2-4-7-21)19-11-9-18(10-12-19)25-31-23-14-13-20(16-24(23)32-25)27(34)30-22-8-5-15-28-17-22;32-25(28-20-5-2-1-3-6-20)18-10-8-17(9-11-18)24-30-22-13-12-19(15-23(22)31-24)26(33)29-21-7-4-14-27-16-21/h2-11,15,19-21H,12-14,16-18H2,1H3,(H,33,37)(H,34,35)(H,36,38);2-11,17-19,23-24,29H,12-16H2,1H3,(H,33,38)(H,34,35)(H,36,37);5,8-17,21H,1-4,6-7H2,(H,29,33)(H,30,34)(H,31,32);4,7-16,20H,1-3,5-6H2,(H,28,32)(H,29,33)(H,30,31)
InChIKeyHONXQKCTLMYVAM-UHFFFAOYSA-N
MW1934.33 g/mol
LogP22.50
Rot. Bonds22

About 2-[4-(1-adamantylcarbamoyl)phenyl]-N-(4-methoxyphenyl)-3H-benzimidazole-5-carboxamide;2-[4-(2-adamantylcarbamoyl)phenyl]-N-(4-methoxyphenyl)-3H-benzimidazole-5-carboxamide;2-[4-(cycloheptylcarbamoyl)phenyl]-N-pyridin-3-yl-3H-benzimidazole-5-carboxamide;2-[4-(cyclohexylcarbamoyl)phenyl]-N-pyridin-3-yl-3H-benzimidazole-5-carboxamide

2-[4-(1-adamantylcarbamoyl)phenyl]-N-(4-methoxyphenyl)-3H-benzimidazole-5-carboxamide;2-[4-(2-adamantylcarbamoyl)phenyl]-N-(4-methoxyphenyl)-3H-benzimidazole-5-carboxamide;2-[4-(cycloheptylcarbamoyl)phenyl]-N-pyridin-3-yl-3H-benzimidazole-5-carboxamide;2-[4-(cyclohexylcarbamoyl)phenyl]-N-pyridin-3-yl-3H-benzimidazole-5-carboxamide (PubChem CID 158541300) has the molecular formula C117H116N18O10 and a molecular weight of 1934.33 g/mol. Its IUPAC name is 2-[4-(1-adamantylcarbamoyl)phenyl]-N-(4-methoxyphenyl)-3H-benzimidazole-5-carboxamide;2-[4-(2-adamantylcarbamoyl)phenyl]-N-(4-methoxyphenyl)-3H-benzimidazole-5-carboxamide;2-[4-(cycloheptylcarbamoyl)phenyl]-N-pyridin-3-yl-3H-benzimidazole-5-carboxamide;2-[4-(cyclohexylcarbamoyl)phenyl]-N-pyridin-3-yl-3H-benzimidazole-5-carboxamide.

Molecular Properties

Compound Name2-[4-(1-adamantylcarbamoyl)phenyl]-N-(4-methoxyphenyl)-3H-benzimidazole-5-carboxamide;2-[4-(2-adamantylcarbamoyl)phenyl]-N-(4-methoxyphenyl)-3H-benzimidazole-5-carboxamide;2-[4-(cycloheptylcarbamoyl)phenyl]-N-pyridin-3-yl-3H-benzimidazole-5-carboxamide;2-[4-(cyclohexylcarbamoyl)phenyl]-N-pyridin-3-yl-3H-benzimidazole-5-carboxamide
PubChem CID158541300
Molecular FormulaC117H116N18O10
Molecular Weight1934.33 g/mol
Exact Mass1932.91
IUPAC Name2-[4-(1-adamantylcarbamoyl)phenyl]-N-(4-methoxyphenyl)-3H-benzimidazole-5-carboxamide;2-[4-(2-adamantylcarbamoyl)phenyl]-N-(4-methoxyphenyl)-3H-benzimidazole-5-carboxamide;2-[4-(cycloheptylcarbamoyl)phenyl]-N-pyridin-3-yl-3H-benzimidazole-5-carboxamide;2-[4-(cyclohexylcarbamoyl)phenyl]-N-pyridin-3-yl-3H-benzimidazole-5-carboxamide
SMILESCOc1ccc(NC(=O)c2ccc3nc(-c4ccc(C(=O)NC56CC7CC(CC(C7)C5)C6)cc4)[nH]c3c2)cc1.COc1ccc(NC(=O)c2ccc3nc(-c4ccc(C(=O)NC5C6CC7CC(C6)CC5C7)cc4)[nH]c3c2)cc1.O=C(Nc1cccnc1)c1ccc2nc(-c3ccc(C(=O)NC4CCCCC4)cc3)[nH]c2c1.O=C(Nc1cccnc1)c1ccc2nc(-c3ccc(C(=O)NC4CCCCCC4)cc3)[nH]c2c1
InChIInChI=1S/2C32H32N4O3.C27H27N5O2.C26H25N5O2/c1-39-26-9-7-25(8-10-26)33-30(37)24-6-11-27-28(15-24)35-29(34-27)22-2-4-23(5-3-22)31(38)36-32-16-19-12-20(17-32)14-21(13-19)18-32;1-39-26-9-7-25(8-10-26)33-32(38)22-6-11-27-28(17-22)35-30(34-27)20-2-4-21(5-3-20)31(37)36-29-23-13-18-12-19(15-23)16-24(29)14-18;33-26(29-21-6-3-1-2-4-7-21)19-11-9-18(10-12-19)25-31-23-14-13-20(16-24(23)32-25)27(34)30-22-8-5-15-28-17-22;32-25(28-20-5-2-1-3-6-20)18-10-8-17(9-11-18)24-30-22-13-12-19(15-23(22)31-24)26(33)29-21-7-4-14-27-16-21/h2-11,15,19-21H,12-14,16-18H2,1H3,(H,33,37)(H,34,35)(H,36,38);2-11,17-19,23-24,29H,12-16H2,1H3,(H,33,38)(H,34,35)(H,36,37);5,8-17,21H,1-4,6-7H2,(H,29,33)(H,30,34)(H,31,32);4,7-16,20H,1-3,5-6H2,(H,28,32)(H,29,33)(H,30,31)
InChIKeyHONXQKCTLMYVAM-UHFFFAOYSA-N
XLogP22.50
TPSA391.76 Ų
H-Bond Donors12
H-Bond Acceptors16
Rotatable Bonds22
Heavy Atoms145
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001934.33
LogP ≤ 522.50
H-Bond Donors ≤ 512
H-Bond Acceptors ≤ 1016

Analyze 2-[4-(1-adamantylcarbamoyl)phenyl]-N-(4-methoxyphenyl)-3H-benzimidazole-5-carboxamide;2-[4-(2-adamantylcarbamoyl)phenyl]-N-(4-methoxyphenyl)-3H-benzimidazole-5-carboxamide;2-[4-(cycloheptylcarbamoyl)phenyl]-N-pyridin-3-yl-3H-benzimidazole-5-carboxamide;2-[4-(cyclohexylcarbamoyl)phenyl]-N-pyridin-3-yl-3H-benzimidazole-5-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-[4-(1-adamantylcarbamoyl)phenyl]-N-(4-methoxyphenyl)-3H-benzimidazole-5-carboxamide;2-[4-(2-adamantylcarbamoyl)phenyl]-N-(4-methoxyphenyl)-3H-benzimidazole-5-carboxamide;2-[4-(cycloheptylcarbamoyl)phenyl]-N-pyridin-3-yl-3H-benzimidazole-5-carboxamide;2-[4-(cyclohexylcarbamoyl)phenyl]-N-pyridin-3-yl-3H-benzimidazole-5-carboxamide?
The IUPAC name of 2-[4-(1-adamantylcarbamoyl)phenyl]-N-(4-methoxyphenyl)-3H-benzimidazole-5-carboxamide;2-[4-(2-adamantylcarbamoyl)phenyl]-N-(4-methoxyphenyl)-3H-benzimidazole-5-carboxamide;2-[4-(cycloheptylcarbamoyl)phenyl]-N-pyridin-3-yl-3H-benzimidazole-5-carboxamide;2-[4-(cyclohexylcarbamoyl)phenyl]-N-pyridin-3-yl-3H-benzimidazole-5-carboxamide (CID 158541300) is 2-[4-(1-adamantylcarbamoyl)phenyl]-N-(4-methoxyphenyl)-3H-benzimidazole-5-carboxamide;2-[4-(2-adamantylcarbamoyl)phenyl]-N-(4-methoxyphenyl)-3H-benzimidazole-5-carboxamide;2-[4-(cycloheptylcarbamoyl)phenyl]-N-pyridin-3-yl-3H-benzimidazole-5-carboxamide;2-[4-(cyclohexylcarbamoyl)phenyl]-N-pyridin-3-yl-3H-benzimidazole-5-carboxamide.
What is the SMILES notation for 2-[4-(1-adamantylcarbamoyl)phenyl]-N-(4-methoxyphenyl)-3H-benzimidazole-5-carboxamide;2-[4-(2-adamantylcarbamoyl)phenyl]-N-(4-methoxyphenyl)-3H-benzimidazole-5-carboxamide;2-[4-(cycloheptylcarbamoyl)phenyl]-N-pyridin-3-yl-3H-benzimidazole-5-carboxamide;2-[4-(cyclohexylcarbamoyl)phenyl]-N-pyridin-3-yl-3H-benzimidazole-5-carboxamide?
The canonical SMILES for 2-[4-(1-adamantylcarbamoyl)phenyl]-N-(4-methoxyphenyl)-3H-benzimidazole-5-carboxamide;2-[4-(2-adamantylcarbamoyl)phenyl]-N-(4-methoxyphenyl)-3H-benzimidazole-5-carboxamide;2-[4-(cycloheptylcarbamoyl)phenyl]-N-pyridin-3-yl-3H-benzimidazole-5-carboxamide;2-[4-(cyclohexylcarbamoyl)phenyl]-N-pyridin-3-yl-3H-benzimidazole-5-carboxamide is COc1ccc(NC(=O)c2ccc3nc(-c4ccc(C(=O)NC56CC7CC(CC(C7)C5)C6)cc4)[nH]c3c2)cc1.COc1ccc(NC(=O)c2ccc3nc(-c4ccc(C(=O)NC5C6CC7CC(C6)CC5C7)cc4)[nH]c3c2)cc1.O=C(Nc1cccnc1)c1ccc2nc(-c3ccc(C(=O)NC4CCCCC4)cc3)[nH]c2c1.O=C(Nc1cccnc1)c1ccc2nc(-c3ccc(C(=O)NC4CCCCCC4)cc3)[nH]c2c1.
What is the InChIKey of 2-[4-(1-adamantylcarbamoyl)phenyl]-N-(4-methoxyphenyl)-3H-benzimidazole-5-carboxamide;2-[4-(2-adamantylcarbamoyl)phenyl]-N-(4-methoxyphenyl)-3H-benzimidazole-5-carboxamide;2-[4-(cycloheptylcarbamoyl)phenyl]-N-pyridin-3-yl-3H-benzimidazole-5-carboxamide;2-[4-(cyclohexylcarbamoyl)phenyl]-N-pyridin-3-yl-3H-benzimidazole-5-carboxamide?
The InChIKey is HONXQKCTLMYVAM-UHFFFAOYSA-N. The full InChI is InChI=1S/2C32H32N4O3.C27H27N5O2.C26H25N5O2/c1-39-26-9-7-25(8-10-26)33-30(37)24-6-11-27-28(15-24)35-29(34-27)22-2-4-23(5-3-22)31(38)36-32-16-19-12-20(17-32)14-21(13-19)18-32;1-39-26-9-7-25(8-10-26)33-32(38)22-6-11-27-28(17-22)35-30(34-27)20-2-4-21(5-3-20)31(37)36-29-23-13-18-12-19(15-23)16-24(29)14-18;33-26(29-21-6-3-1-2-4-7-21)19-11-9-18(10-12-19)25-31-23-14-13-20(16-24(23)32-25)27(34)30-22-8-5-15-28-17-22;32-25(28-20-5-2-1-3-6-20)18-10-8-17(9-11-18)24-30-22-13-12-19(15-23(22)31-24)26(33)29-21-7-4-14-27-16-21/h2-11,15,19-21H,12-14,16-18H2,1H3,(H,33,37)(H,34,35)(H,36,38);2-11,17-19,23-24,29H,12-16H2,1H3,(H,33,38)(H,34,35)(H,36,37);5,8-17,21H,1-4,6-7H2,(H,29,33)(H,30,34)(H,31,32);4,7-16,20H,1-3,5-6H2,(H,28,32)(H,29,33)(H,30,31).
What are the key properties of 2-[4-(1-adamantylcarbamoyl)phenyl]-N-(4-methoxyphenyl)-3H-benzimidazole-5-carboxamide;2-[4-(2-adamantylcarbamoyl)phenyl]-N-(4-methoxyphenyl)-3H-benzimidazole-5-carboxamide;2-[4-(cycloheptylcarbamoyl)phenyl]-N-pyridin-3-yl-3H-benzimidazole-5-carboxamide;2-[4-(cyclohexylcarbamoyl)phenyl]-N-pyridin-3-yl-3H-benzimidazole-5-carboxamide?
2-[4-(1-adamantylcarbamoyl)phenyl]-N-(4-methoxyphenyl)-3H-benzimidazole-5-carboxamide;2-[4-(2-adamantylcarbamoyl)phenyl]-N-(4-methoxyphenyl)-3H-benzimidazole-5-carboxamide;2-[4-(cycloheptylcarbamoyl)phenyl]-N-pyridin-3-yl-3H-benzimidazole-5-carboxamide;2-[4-(cyclohexylcarbamoyl)phenyl]-N-pyridin-3-yl-3H-benzimidazole-5-carboxamide has a molecular weight of 1934.33 g/mol, XLogP of 22.50, 22 rotatable bonds, 12 hydrogen bond donors, and 16 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[4-(1-adamantylcarbamoyl)phenyl]-N-(4-methoxyphenyl)-3H-benzimidazole-5-carboxamide;2-[4-(2-adamantylcarbamoyl)phenyl]-N-(4-methoxyphenyl)-3H-benzimidazole-5-carboxamide;2-[4-(cycloheptylcarbamoyl)phenyl]-N-pyridin-3-yl-3H-benzimidazole-5-carboxamide;2-[4-(cyclohexylcarbamoyl)phenyl]-N-pyridin-3-yl-3H-benzimidazole-5-carboxamide is sourced from PubChem (CID 158541300), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).